Postoperative pulmonary complications following thoracic surgery during COVID-19 pandemic
- VernacularTitle:新型冠状病毒肺炎疫情背景下胸外科术后肺部并发症的应对策略
- Author:
Maodan YANG
1
;
Lingli NIU
2
;
Zhu WU
2
;
Chengwu LIU
2
;
Xiaolong ZHANG
2
;
Wenping WANG
2
Author Information
1. Department of Thoracic Surgery, Shangjin Nanfu Hospital (Shangjin Branch of West China Hospital), Chengdu, 611743, P. R. China
2. Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu, 610041, P. R. China
- Publication Type:Journal Article
- Keywords:
Thoracic surgery;
postoperative complications;
fever;
pulmonary complications;
COVID-19 pneumonia
- From:
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery
2022;29(08):1024-1030
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the treatment strategies for patients with fever and pulmonary complications after thoracic surgery during COVID-19 epidemic. Methods The clinical data of 537 patients who ungerwent selective surgery at the Department of Thoracic Surgery, Shangjin Branch of West China Hospital between February and December 2020 were retrospectively analyzed, including 242 (45.1%) males and 295 (54.9%) females aged 53.3±13.4 years. We have established a procedure for the patients with fever and pulmonary complications after thoracic surgery to investigate the cause of the disease and track risk factors. Results The overall postoperative complication rate was 16.4% (88/537), and 1 (0.2%) patient died. Of 537 patients, 179 (33.3%) patients were enrolled in our model according to the inclusion criteria: ratio of males [112 (62.6%) vs. 130 (36.3%), P<0.010], patients with a history of smoking [74 (41.3%) vs. 87 (24.3%), P<0.010], or with esophageal cancer surgery [36 (20.1%) vs. 15 (4.2%)], or with traditional thoracotomy [14 (7.8%) vs. 4 (1.1%)] was higher than that of the other patients. Patients in our process due to fever or pulmonary complications had longer ICU stay and postoperative hospital stay (P=0.010). Logistic regression multivariate analysis showed that gender was an independent risk factor for postoperative fever or pulmonary complications. Conclusion In low-risk areas of the epidemic, the treatment process is simple and feasible, and the cause traceability and corresponding treatment can basically be completed within 24 hours. At the same time, the treatment process has been running stably for a long time.
